Article info
PDFOriginal articles
Growth factor-based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single-blind, randomised trial of autologous blood injections versus platelet-rich plasma injections
- Correspondence to Dr Leon Creaney, BUPA Health and Wellbeing, 3 White Lyon Court, London EC2Y 8EA, UK; leoncreaney{at}hotmail.com
Citation
Growth factor-based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single-blind, randomised trial of autologous blood injections versus platelet-rich plasma injections
Publication history
- Accepted February 3, 2011
- First published March 15, 2011.
Online issue publication
October 11, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions